← FDA DRUG APPROVALS

FDA ANDA · ANDA204318

PHENTERMINE

phentermine hydrochloride

Sponsor: AUROLIFE PHARMA LLC

APPLICATION
ANDA204318
TYPE
ANDA
ORIGINAL APPROVAL
2016-11-09
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

PHENTERMINE HYDROCHLORIDEPrescription
PHENTERMINE HYDROCHLORIDE 30MG · CAPSULE · ORAL
PHENTERMINE HYDROCHLORIDEPrescription
PHENTERMINE HYDROCHLORIDE 15MG · CAPSULE · ORAL

Approval history

2017-05-31Labeling · Supplement 1 · standardAP
2016-11-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →